Pandemic Response: Scaling and Collaborating in the Face of the Coronavirus

COVID-19 has challenged our community to deliver new diagnostic platforms, production processes, and therapeutic modalities. What has COVID taught us about going from concept to solution at speed? What are the realities of making these solutions robust and economically viable, often in partnership with others? From drug makers to technology providers, this session brings together diverse perspectives on vaccines, diagnostics, and novel therapeutics in the pandemic response.